Sensex, Nifty Brace for Sharp Dip as US-Iran Tensions Trigger Global Market Jitters
The Bearish Outlook: Geopolitical Tensions Drive Monday Dip
The Indian stock market is bracing for a potentially negative start on Monday, April 13, 2026. Global sentiment remains weak as investors assess the fallout from failed US-Iran ceasefire talks. Concerns are heightened by reports of a US naval blockade on Iranian ports, intensifying geopolitical uncertainty.Market data suggests a subdued opening for domestic equities. Gift Nifty is indicating a notable gap-down, positioning the index near the 23,700 zone. This reflects deteriorating global sentiment following fresh escalations in the Middle East conflict.
Weekly Market Performance Recap: Rally Amid Initial Optimism
Despite the expected dip, the market closed sharply higher on Friday. Both benchmark indices displayed strong upward momentum on Friday. The Sensex surged 919 points, marking a 1.20% increase, and closing at 77,550.25.The Nifty 50 also climbed over 1%, gaining 276 points and finishing the session at 24,050.60. This significant rally had been fueled by initial optimism surrounding potential developments in the US-Iran war talks.
Corporate Highlights: Key Developments in 10 Stocks
Amid the backdrop of global volatility, ten stocks are particularly drawing focus due to significant operational and corporate developments.Sectoral and Corporate News Flow
Mahindra & Mahindra (M&M) saw its stock focus bolstered by stronger production and sales figures for March 2026, particularly within its utility vehicles segment. Muthoot Finance announced a substantial interim dividend, approving ₹ 30 per equity share, or 300% for the fiscal year 2025-26.
Adani Green Energy reported a major milestone, stating that its operational capacity grew 35% year-on-year to 19.3 GW. Larsen & Toubro (L&T) also featured a key corporate move, with its subsidiary, L&T Realty Properties, acquiring a 100% stake in International Green Scapes.
Pharmaceutical and Infrastructure Updates
The pharmaceutical sector saw several noteworthy developments. Lupin introduced Dapagliflozin tablets (5 mg and 10 mg) in the United States after receiving US FDA approval, noting the drug's bioequivalence to Farxiga. AstraZeneca received Central Drugs Standard Control Organisation approval to import, market, and distribute Acalabrutinib tablets (100 mg).
On the infrastructure and finance side, Enviro Infra Engineers secured two projects valued at ₹ 972.2 crore from the Swachh Maharashtra Mission Directorate. Furthermore, General Insurance Corporation of India (state-owned reinsurer) announced receiving a demand notice under Section 156 of the Income Tax Act, 1961, for ₹ 350.47 crore.
Tech and Pharma Activity
In the technology space, Swiggy signaled a major leadership transition with its co-founder, Nandan Reddy, resigning from the board. Regarding pharmaceuticals, Torrent Pharma stated that the US FDA conducted an inspection of its oncology facility in Bileshwarpura, Gujarat, between April 6 and April 10.
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.